Clinical Research Fellow (ST3+) Medical Oncology

Applications are invited for the post of Clinical Research Fellow in Cancer Drug Development. The aim of this position is to offer comprehensive specialist training in all aspects of running early phase oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings. Support and opportunities for pursuing higher research degrees are also available., The aim of this position is to offer comprehensive specialist training in all aspects of running early phase oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings.

These full-time posts are available now and will be for a period of up to 12 months in the first instance and there is potential opportunity to extend beyond 12 months. Applicants must demonstrate as part of their application, how they meet the essential requirements of the post. In particular, applicants should have a medical degree and GMC registration. Experience in oncology and clinical research are an advantage. Fluency in English and aptitude with writing and publishing manuscripts are essential

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites:

• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing), We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.